2025-10-19 - Analysis Report
Okay, here's an analysis of SUI-USD (Sui) based on the provided data, presented in English with key figures and a brief analysis.

**Report on SUI-USD (Sui)**

**Company Overview:** Sui is briefly described as a company (no further detail provided).

**1. Performance vs. S&P 500 (VOO)**

*   **Sui Cumulative Return:** -82.03%
*   **VOO (S&P 500) Cumulative Return:** 19.41%
*   **Deviation:** Current Deviation = -101.4 (Max: 147.5, Min: -114.2)
*   **Relative Deviation:** 4.9

**Analysis:** Sui has significantly underperformed the S&P 500 (VOO).  The current deviation is -101.4, meaning Sui's return is 101.4 percentage points lower than the S&P 500's return. The relative deviation of 4.9 suggests that the current deviation is near the lower end of its historical range compared to VOO.

**Alpha, Beta Analysis:**

| Year      | CAGR   | MDD    | Alpha   | Beta | Cap(B) |
| :---------- | :----- | :----- | :------ | :--- | :----- |
| 2023-2025 | -82.0% | 95.2%  | -99.0% | 0.0 | 0.0  |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):** -82.0% indicates a very significant negative average annual return over the period.
*   **MDD (Maximum Drawdown):** 95.2% signifies a very large potential loss from peak to trough.
*   **Alpha:** -99.0% suggests substantial underperformance relative to the benchmark, not explained by market movements.
*   **Beta:** 0.0 indicates no correlation with the market (S&P 500).

**2. Recent Price Action**

*   **Current Price:** 0.0003001941
*   **Last Market:** price same as previousClose, change is 0
*   **5-Day Moving Average:** 0.0003
*   **20-Day Moving Average:** 0.0003
*   **60-Day Moving Average:** 0.0004

**Analysis:** The price is extremely low and has remained stable at a very low value for the past 5 and 20 days. The 60-day moving average is slightly higher, indicating a gradual decline over a longer period. The "Last Market" data shows no change in price, indicating no significant recent price movement.

**3. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.7 (Medium Investment)
*   **RSI:** 42.71
*   **PPO:** -1.36
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (10 shares - Caution - MRI:0.70)
*   **Recent (20-day) Relative Deviation Change:** 0.7 (+) - Short-term Increase
*   **Expected Return (%):** 292.6%

**Analysis:**

*   **MRI:** A value of 0.7 suggests a medium level of investment risk.
*   **RSI:** An RSI of 42.71 is neutral, not indicating overbought or oversold conditions.
*   **PPO:** A negative PPO (-1.36) suggests the short-term moving average is below the long-term moving average, indicating a potential downtrend.
*   **Hybrid Signal:** This signal suggests a cautious buy recommendation (80% of available cash, with a small share allocation), and it also emphasizing the MRI rating.
*   **Relative Deviation Change:** The positive change in relative deviation suggests that the stock's performance relative to the S&P 500 has slightly improved recently.
*   **Expected Return:** A high expected return of 292.6% suggests potential for significant gains if held as a long-term investment compared to S&P 500.

**4. Recent News & Significant Events:**

*   **[2025-10-19] Returns At Kingfisher (LON:KGF) Appear To Be Weighed Down (Simply Wall St.)**
*   **[2025-10-19] Market Sentiment Around Loss-Making HomeToGo SE (ETR:HTG) (Simply Wall St.)**
*   **[2025-10-19] Tubulis Presents First Clinical Data from Phase I/IIa Trial for TUB-040 in Platinum-Resistant Ovarian Cancer (PROC) at ESMO 2025 (Business Wire)**
*   **[2025-10-19] Verastem Oncology Announces Updated Data from Partner GenFleet Therapeutics’ Phase 1/2 Monotherapy Study in China of GFH375 (VS-7375) in Advanced KRAS G12D Mutant Pancreatic Ductal Adenocarcinoma (Business Wire)**
*   **[2025-10-19] XTANDI® Plus Leuprolide Reduced Risk of Death by 40% vs Leuprolide Alone in Men with a Type of Advanced Prostate Cancer (Business Wire)**
*   **[2025-10-19] Breakthroughs in Energy and Power, Advancements in Intelligent Technology -- The 2025 Chery International Technology Night (PR Newswire)**

**Analysis:** The provided news headlines appear to be unrelated to SUI-USD (Sui). They cover a variety of companies and industries.  Therefore, they don't offer any specific insights into the company's current situation.

**4-2. Analyst Opinions**
*   No Analyst Consensus data provided.

**5. Overall Assessment:**

SUI-USD (Sui) has performed very poorly compared to the S&P 500, with a large negative cumulative return and a substantial negative alpha. The current price is extremely low, and recent price action indicates a lack of significant movement. Technical indicators suggest a medium level of risk, but the hybrid signal points towards a cautious buy recommendation with a small allocation. The recent positive change in relative deviation offers a glimmer of hope, and the high expected return suggests potential for long-term gains. However, the extremely negative past performance and the lack of company-specific news or analyst opinions raise significant concerns. The provided news headlines are irrelevant to SUI-USD.

**Recommendation:**

Given the extremely poor historical performance and the limited available information, a **high degree of caution** is advised. More research is needed to understand the underlying reasons for the underperformance and to assess the company's future prospects. While the hybrid signal suggests a cautious buy, this should only be considered after a thorough investigation and with a very small, speculative allocation.
